Clinical Trial

Cellulitis Optimal Antibiotic Treatment

Study acronym: COAT
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To determine whether a short course of oral flucloxacillin (5 days) is non-inferior to a standard course (7 days) in terms of pain over days 6-14 (indicative of persistence or recurrence associated with the symptoms of most importance to patients) in adults with cellulitis of the leg presenting in primary care.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-10-13; most recent amendment 2026-05-14.
Status change: Not Yet Recruiting → Recruiting 2024-12-04
Trial Details
NCT Number NCT05584007
Lead Sponsor University of Southampton
Collaborators: University of East Anglia, University of Nottingham, Norfolk and Norwich University Hospitals NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust
Conditions Cellulitis of Leg
Enrollment 334 participants
Start Date 2023-08-29
Primary Completion 2026-05 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-15